Gemigliptin added to ongoing metformin therapy provides sustained glycaemic control over 52 weeks and was well tolerated in patients with type 2 diabetes

被引：0

作者：

Rhee, E. J. ^{[1
]}

Min, K. W. ^{[2
]}

Jang, H. C. ^{[3
]}

Chung, C. H. ^{[4
]}

Nam-Goong, I. S. ^{[5
]}

Bae, H. Y. ^{[6
]}

Baik, S. H. ^{[7
]}

Shivane, V. K. ^{[8
]}

Sosale, A. R. ^{[9
]}

Dharmalingam, M. ^{[10
]}

Gandhi, P. ^{[11
]}

Gupta, S. K. ^{[12
]}

Ahn, J. Y. ^{[13
]}

Bang, K. S. ^{[13
]}

Lee, M. K. ^{[14
]}

机构：

[1] Kangbuk Samsung Med Ctr, Seoul, South Korea

[2] Eulji Univ, Sch Med, Seoul, South Korea

[3] Seoul Natl Univ, Bundang Hosp, Songnam, South Korea

[4] Wonju Christian Hosp, Wonju, South Korea

[5] Ulsan Univ Hosp, Ulsan, South Korea

[6] Chosun Univ Hosp, Kwangju, South Korea

[7] Korea Univ, Guro Hosp, Seoul, South Korea

[8] Shivane, Mumbai, Maharashtra, India

[9] Diacon Hosp, Diabet Care & Res Ctr, Bangalore, Karnataka, India

[10] Bangalore Endocrinol & Diabet Res Ctr, Bangalore, Karnataka, India

[11] Gandhi Res Inst, Nagpur, Maharashtra, India

[12] MV Hosp & Res Ctr, Lucknow, Uttar Pradesh, India

[13] LG Life Sci, Seoul, South Korea

[14] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Seoul, South Korea

来源：

DIABETOLOGIA | 2013年 / 56卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

111

引用

页码：S52 / S52

页数：1

共 50 条

[41] Saxagliptin improves glycaemic control either as add-on therapy to metformin or as initial combination therapy with metformin in patients with type 2 diabetes [J].

Pfuetzner, A. ;

Gurieva, I ;

Antsiferov, M. ;

Allen, E. ;

Ravichandran, S. ;

Chen, R. .

SWISS MEDICAL WEEKLY, 2009, 139 (33-34) :168S-169S

[42] Saxagliptin improves glycaemic control either as add-on therapy to metformin or as initial combination therapy with metformin in patients with type 2 diabetes [J].

Gurieva, I. ;

Pfuetzner, A. ;

Antsiferov, M. ;

Allen, E. ;

Ravichandran, S. ;

Chen, R. .

EUROPEAN HEART JOURNAL, 2009, 30 :226-227

[43] A Randomized Controlled Trial of R-Form Verapamil Added to Ongoing Metformin Therapy in Patients with Type 2 Diabetes [J].

Wang, Chih-Yuan ;

Huang, Kuo-Chin ;

Lu, Chia-Wen ;

Chu, Chih-Hsun ;

Huang, Chien-Ning ;

Chen, Harn-Shen ;

Lee, I-Te ;

Chen, Jung-Fu ;

Chen, Ching-Chu ;

Chen, Chung-Sen ;

Hsieh, Chang-Hsun ;

Tien, Kai-Jen ;

Chien, Hung-Yu ;

Huang, Yu-Yao ;

Hsu, Jui-Pao ;

Shane, Guang-Tzuu ;

Chang, Ai-Ching ;

Wu, Yen-Chieh ;

Sheu, Wayne Huey-Herng .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2022, 107 (10) :E4063-E4071

[44] Improvement in glycaemic control and reduction in body weight over 52 weeks with dapagliflozin as add-on therapy to metformin plus sulphonylurea [J].

Matthaei, S. ;

Bowering, K. ;

Rohwedder, K. ;

Grohl, A. ;

Johnsson, E. .

DIABETOLOGIA, 2014, 57 :S347-S347

[45] Initial treatment with metformin plus colesevelam provides greater glycaemic control than metformin alone in Hispanic patients with type 2 diabetes mellitus [J].

Hernandez-Triana, E. ;

Garvey, W. T. ;

Goldberg, R. B. ;

Handelsman, Y. ;

Fonseca, V. A. ;

Jones, M. R. ;

Abby, S. L. ;

Markiewicz, M. ;

Jin, X. ;

Misir, S. ;

Nagendran, S. ;

Rosenstock, J. .

DIABETOLOGIA, 2010, 53

[46] Sustained improvement of glycaemic control by insulin treatment in patients with type 2 diabetes [J].

Lindström, T .

DIABETOLOGIA, 1998, 41 :A248-A248

[47] Rosiglitazone in combination with glibenclamide plus metformin is effective and well tolerated in Type 2 diabetes patients [J].

Jones, N ;

Jones, T ;

Menci, L ;

Xu, J ;

Freed, M ;

Kreider, M .

DIABETOLOGIA, 2001, 44 :A235-A235

[48] Improvement in glycaemic control with rosiglitazone/metformin fixed-dose combination therapy in patients with type 2 diabetes with very poor glycaemic control [J].

Rosenstock, J. ;

Rood, J. ;

Cobitz, A. ;

Huang, C. ;

Garber, A. .

DIABETES OBESITY & METABOLISM, 2006, 8 (06) :643-649

[49] Vildagliptin plus metformin combination therapy provides superior glycaemic control to individual monotherapy in treatment-naive patients with type 2 diabetes mellitus [J].

Bosi, E. ;

Dotta, F. ;

Jia, Y. ;

Goodman, M. .

DIABETES OBESITY & METABOLISM, 2009, 11 (05) :506-515

[50] Two-year treatment with sitagliptin and initial combination therapy of sitagliptin and metformin provides substantial and durable glycaemic control in patients with type 2 diabetes [J].

Qi, D. S. ;

Teng, R. ;

Jiang, M. ;

Davies, M. J. ;

Kaufman, K. D. ;

Amatruda, J. M. ;

Williams-Herman, D. .

DIABETOLOGIA, 2008, 51 :S36-S36

← 1 2 3 4 5 →